Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.
Diabetes Metab Syndr
; 14(4): 273-276, 2020.
Article
in English
| MEDLINE | ID: covidwho-30764
ABSTRACT
BACKGROUND AND AIMS:
In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario.METHODS:
PubMed and Google Scholar search engines were searched using the key terms 'telemedicine', 'diabetes', 'COVID-19 up to 31st March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India, were accessed.RESULTS:
We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations.CONCLUSIONS:
Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Telemedicine
/
Coronavirus Infections
/
Diabetes Mellitus
/
Pandemics
/
Betacoronavirus
Type of study:
Observational study
/
Prognostic study
/
Reviews
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Diabetes Metab Syndr
Year:
2020
Document Type:
Article
Affiliation country:
J.dsx.2020.04.001
Similar
MEDLINE
...
LILACS
LIS